Media Contact:
Stephen Majors
Senior Director, Public Affairs
smajors@alliancerm.org
Carlsbad, CA
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today announced the election of its 2023 Officers, Executive Committee, and Board of Directors.
Washington, D.C.
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector, today formally announced that its Board of Directors has appointed Timothy D. Hunt as the organization’s next Chief Executive Officer.
Washington, DC
The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released Project A-Cell, a multistakeholder collaboration to incorporate Quality by Design (QbD) principles into a manufacturing case study of a Chimeric Antigen Receptor T-cell (CAR-T) therapy.
Washington, DC
The European Commission’s proposed ‘Substances of Human Origin’ (SoHO) Regulation holds the promise of improving patient safety while establishing greater legal and regulatory certainty across the EU.
